Last reviewed · How we verify

NCT05419414

The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis

Completed NA Last updated 15 June 2022
What this trial tests

NA trial testing Shear wave elastography in Adenomyosis in 65 participants. Completed in 1 January 2022.

Timeline
1 October 2018
Primary endpoint
1 October 2021
1 January 2022

Quick facts

Lead sponsorIstanbul University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment65
Start date1 October 2018
Primary completion1 October 2021
Estimated completion1 January 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University

Who can join

Adults 18 to 60, female only, with Adenomyosis or Elastography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this prospective cohort study, the patients who were diagnosed with either uterine fibroid (control group) or adenomyosis (study group), were examined with transvaginal ultrasound and shear wave elastography. Definitive diagnosis was established by pelvic MRI. Shear wave elastography data of both groups were compared. Features of adenomyosis on transvaginal ultrasound were also recorded for study group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Shear wave elastography

Trials testing the same drug.

Other recruiting trials for Adenomyosis

Currently open trials in the same condition.

Other Istanbul University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05419414.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing